This review shows that insulin analogs are cost-effective versus human insulins based on pharmacoeconomic models and retrospective database analyses.
Carrie McAdam-Marx, RPh, MS
Advertisement
Articles by Carrie McAdam-Marx, RPh, MS
Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.
Advertisement
Latest Updated Articles
- Cost-Effectiveness of Insulin Analogs
Published: November 15th 2008 | Updated:
- Systematic Analysis of Outcomes Evaluations Applied to Drug Management Programs
Published: November 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
Value-Based Care Interventions and Management of CKD Progression
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5
